文献
J-GLOBAL ID:201102233684403359
整理番号:11A0478307
切除不能な膵臓癌の日本人患者におけるエルロチニブとゲムシタビンの併用効果のフェーズII試験
Phase II study of erlotinib plus gemcitabine in Japanese patients with unresectable pancreatic cancer
著者 (14件):
OKUSAKA Takuji
(National Cancer Center Hospital, Tokyo)
,
FURUSE Junji
(National Cancer Center Hospital East, Kashiwa)
,
FURUSE Junji
(Kyorin Univ. School of Medicine, Tokyo)
,
FUNAKOSHI Akihiro
(National Kyushu Cancer Center, Fukuoka)
,
IOKA Tatsuya
(Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka)
,
YAMAO Kenji
(Aichi Cancer Center Hospital, Nagoya)
,
OHKAWA Shinichi
(Kanagawa Cancer Center Hospital, Yokohama)
,
BOKU Narikazu
(Shizuoka Cancer Center, Shizuoka)
,
KOMATSU Yoshito
(Hokkaido Univ. Hospital, Sapporo)
,
NAKAMORI Shoji
(Osaka National Hospital, Osaka)
,
IGUCHI Haruo
(Shikoku Cancer Center, Ehime)
,
ITO Tetsuhide
(Kyushu Univ., Fukuoka)
,
NAKAGAWA Kazuhiko
(Kinki Univ. School of Medicine, Osaka, JPN)
,
NAKACHI Kohei
(National Cancer Center Hospital East, Kashiwa)
資料名:
Cancer Science
(Cancer Science)
巻:
102
号:
2
ページ:
425-431
発行年:
2011年02月
JST資料番号:
W1423A
ISSN:
1347-9032
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オーストラリア (AUS)
言語:
英語 (EN)